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Objectives The objective of this study was to test the hypothesis that gastric bypass surgery (GBS) would favorably impact
cardiac remodeling and function.
Background GBS is increasingly used to treat severe obesity, but there are limited outcome data.
Methods We prospectively studied 423 severely obese patients undergoing GBS and a reference group of severely obese
subjects that did not have surgery (n  733).
Results At a 2-year follow up, GBS subjects had a large reduction in body mass index compared with the reference group
(15.4  7.2 kg/m2 vs. 0.03  4.0 kg/m2; p  0.0001), as well as significant reductions in waist circumfer-
ence, systolic blood pressure, heart rate, triglycerides, low-density lipoprotein cholesterol, and insulin resistance.
High-density lipoprotein cholesterol increased. The GBS group had reductions in left ventricular (LV) mass index
and right ventricular (RV) cavity area. Left atrial volume did not change in GBS but increased in reference sub-
jects. In conjunction with reduced chamber sizes, GBS subjects also had increased LV midwall fractional shorten-
ing and RV fractional area change. In multivariable analysis, age, change in body mass index, severity of noctur-
nal hypoxemia, E/E=, and sex were independently associated with LV mass index, whereas surgical status,
change in waist circumference, and change in insulin resistance were not.
Conclusions Marked weight loss in patients undergoing GBS was associated with reverse cardiac remodeling and improved
LV and RV function. These data support the use of bariatric surgery to prevent cardiovascular complications in
severe obesity. (J Am Coll Cardiol 2011;57:732–9) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.10.017Obesity is associated with increased risks of developing
heart failure (1) and atrial fibrillation (2) and with an
increased overall risk of death, mainly from cardiovascular
causes (3–7). Obese subjects commonly have evidence of
cardiac remodeling, including left ventricular (LV) hyper-
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2010, accepted October 1, 2010.trophy (8–16) and left atrial (LA) enlargement (16,17).
Increased LV mass and LA volume each predict increased
risk of heart failure, atrial fibrillation, and death in popula-
tion studies (2,18–22). Thus, adverse cardiac remodeling
might contribute to the high cardiovascular morbidity and
mortality in obesity.
Bariatric surgery is increasingly being used to treat severe
obesity (23). Despite several calls for outcome data from this
procedure (24), most published studies assessing cardiovas-
cular changes after gastric bypass surgery (GBS) are rela-
tively small and have 1 year or less of follow-up, and only a
few have control or reference groups. We hypothesized that
marked weight loss achieved via GBS would be associated
with reversal of the unfavorable cardiac remodeling and
subclinical contractile dysfunction that is seen in severe
obesity. We prospectively tested this hypothesis in a large
cohort of patients who met criteria for GBS (25). Patients
w
t
h
B
s
T
s
m
T
s
f
o
E
u
i
m
m
733JACC Vol. 57, No. 6, 2011 Owan et al.
February 8, 2011:732–9 Cardiovascular Remodeling With Weight Lossundergoing GBS or nonsurgical therapy (reference) were
studied at baseline (visit 1) and again approximately 2 years
after enrollment (visit 2).
Methods
The University of Utah Institutional Review Board ap-
proved this study. All subjects gave informed consent.
Severely obese subjects who met criteria for bariatric surgery
were recruited into a prospective study examining the
cardiovascular effects of weight loss achieved by Roux en Y
GBS. The study design has been described previously (25).
Three groups of subjects: 1) GBS (n  423); 2) subjects
ho sought GBS, but the procedure was not covered by
heir insurance policy (n  412); and 3) obese subjects not
seeking GBS who were randomly selected from a popula-
tion database (n  321). The third group was included to
elp overcome potential bias related to socioeconomic class.
y study design, echocardiograms were not performed on a
ubset of patients (n  274) from the overall cohort (25).
hese subjects had demographics and clinical characteristics
imilar to those who had echocardiograms done except for
ildly higher blood pressures (Online Appendix Table 1).
he study group in this report consisted of 797 consecutive
ubjects with echocardiogram windows that were suitable
or quantification of LV mass or LA volume. The numbers
f patients included at each visit are shown in Figure 1.
chocardiography. Left ventricular dimensions and vol-
mes were determined from 2-dimensional or M-mode
mages according to established criteria (26,27). These
easurements were used to calculate LV mass using the
odified cube formula (28) and the area-length method
Figure 1 Flow Chart Showing the Numbers of Subjects With Ec
BL  baseline; GBS  gastric bypass surgery.(26). Global LV systolic function
was assessed using LV endocar-
dial fractional shortening and
ejection fraction, and myocardial
function was assessed with midwall
fractional shortening (MWFS)
(26,29). Left ventricular hyper-
trophy was defined using LV
mass/height2.7 with sex-specific
cut-offs (30). The LA volume was
measured in the apical 4-chamber
view at end-systole using the
method of discs. The LA volume
was not indexed to body surface
area because this causes underes-
timation of the relative chamber size in severely obese
subjects. Right ventricular (RV) major and minor axis
dimensions and systolic and diastolic cavity areas were
measured in the apical 4-chamber view. Pulsed-wave Dopp-
ler measurements were recorded at the medial portion of the
mitral annulus to assess the early diastolic myocardial
velocity (E=). The ratio of the early diastolic mitral flow
velocity (E) to E= was used as an index of LV filling pressure
(31). Interobserver and intraobserver variability for the main
measurements have been reported previously (16).
Exercise testing. Submaximal exercise testing was per-
formed using a modified Bruce protocol. Exercise was
terminated when subjects reached 80% of predicted maxi-
mum heart rate because of concerns about the safety of
maximal exercise testing in patients with very large body
habitus.
Abbreviations
and Acronyms
BMI  body mass index
E  early diastolic mitral
flow velocity
E=  early diastolic
myocardial velocity
GBS  gastric bypass
surgery
LV  left ventricular
MWFS  midwall fractional
shortening
RV  right ventricular
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Cardiovascular Remodeling With Weight Loss February 8, 2011:732–9Respiratory measures during sleep. Limited overnight
polysomnography consisted of nasal airflow (using a pres-
sure transducer), thoracic and abdominal effort, snoring,
activity, body position, O2 saturation, and heart rate. Re-
cords were scored blindly.
Statistical analysis. Continuous variables are reported as
means  SD. For normally distributed variables, within-
group changes from baseline to 2 years were compared using
a paired t test, and differences between the groups at each
time point (baseline or 2 years) were compared using an
unpaired t test. The nonparametric Kruskal-Wallis test was
used for between-group comparison, and the Wilcoxon
signed-rank sum test was used to examine within-group
change for variables that were not normally distributed. To
account for incomplete follow-up and missing data, impu-
tation and carry-forward methods were used. Categoric
variables are reported as proportions, and differences were
compared using the chi-square test. Univariate linear regres-
sion was performed using the Pearson correlation. Col-
linearity between selected variables (body mass index [BMI]
and surgical status) was assessed using tolerance and vari-
ance inflation factor. Multiple linear regression analysis was
used to determine the factors that were associated with each
of the 4 main outcome variables (LV mass index, LA
volume, LV MWFS, and RV fractional area change) at the
2-year follow-up. For all 3 analyses, the variables used in the
initial and final models were chosen based on clinical
relevance or a plausible role in a causal pathway that might
affect these outcome variables. Two sets of models were
constructed. The first (model 1) used changes in clinical
parameters between visits 1 and 2 as the input variables,
with the absolute value of LV mass index, LA volume, and
LV MWFS at visit 2 as the outcome variable. This
approach was employed in an effort to minimize the effects
Clinical Characteristics of the GBS and Denied-Surgery Reference SParti ipating in the E h cardiographic Analysis at Baseline and 2-YTable 1 Clinical Charact ristics of th GBS nd Den d-Surg ryParticipating in the Echocardiographic Analysis at Bas
Baseline
Denied Surgery
Reference
(n  240)
Not Seeking Surgery
Reference
(n  271)
Age (yrs) 43 11 49 11†
BMI (kg/m2) 46.1 6.2† 43.7 6.2†
Weight (kg) 130 24† 124.7 24.1†
Waist (cm) 134 16 130.4 15†
Height (cm) 168 9 168.6 9.5
Heart rate (beats/min) 74 12§ 74.2 10.7
SBP (mm Hg) 123 17 127.5 18
DBP (mm Hg) 71 10 71.8 10.3†
HbA1C (%) 6.1 1.1 5.9 1.1
Glucose (mg/dl) 109 38 107 33
Plasma insulin (IU) 17.6 13.2† 14.0 13.3†
HOMA-IR 4.8 4.0 3.7 3.8†
*Data are presented as mean (SD). †p  0.05 vs. GBS at baseline. ‡p  0.01 vs. GBS at 2 years.
nterquartile range; for HOMA-IR comparisons done with the nonparametric Kruskal-Wallis test for bet
BMI  body mass index; DBP  diastolic blood pressure; GBS  gastric bypass surgery; HbA1C  gly
ystolic blood pressure.of baseline differences between the groups while maintain-
ing the clinical meaning of absolute measures of LV mass,
LA volume, and MWFS. The second (model 2) used
changes between visit 1 and visit 2 for both input and
outcome variables (Online Appendix Tables 2 to 4). The
initial variables were the same for both models. In each case,
after the initial model was run, backward stepwise regression
analysis was used to successively remove variables from the
model that were not statistically significant. For analyses in
which the mean values of 3 groups were compared, p 0.01
was considered significant. When only 2 groups were
compared, p  0.05 was considered to be significant.
Results
Clinical characteristics. The clinical characteristics of the
study subjects are shown in Table 1. Systolic and diastolic
blood pressures, fasting glucose, and glycosylated hemoglo-
bin levels were all at the upper end of the normal range at
visit 1. Serum insulin levels were markedly elevated. Patients
in the GBS group lost an average of 44 kg (98 lbs) and
decreased their BMI by 15.4 kg/m2 (Table 1). In conjunc-
ion with this marked degree of weight loss, those in the
BS group had improvements in systolic blood pressure,
eart rate, glucose level, insulin level, and homeostasis
odel assessment of insulin resistance (HOMA IR) at visit
compared with baseline and compared with the reference
roups (Table 1). At the 2-year follow-up, there were 2
eaths in the GBS group and 2 deaths in the reference
roup.
hanges in LV geometry after GBS. The echocardio-
raphic findings at baseline have been reported previously
16). In brief, LV cavity dimensions and volumes were
ormal, wall thickness was mildly increased, and the ma-
ctsFollow-Up*rence Subjects
and 2-Year Follow-Up*
2 Yrs
BS
354)
Denied Surgery
Reference
(n  222)
Not Seeking Surgery
Reference
(n  254)
GBS
(n  338)
 11 45 11 49 11‡ 45 11
 7.0 45.4 8.7‡ 44 7.4‡ 32.2 7.8§
 28 126 27‡ 123.3 26.3‡ 91 25§
 18 132 20‡ 131.1 18.8‡ 102 22§
 9 168 9 168.3 9.6 167 9
 12 68 10‡ 67 10‡§ 60 10§
 18 123 17‡ 126.6 19.4‡ 115 18§
 10 71 11 70.3 9.8 69 10
 1.1 5.9 0.8‡ 6.2 0.94‡ 5.6 0.8
 34 102 33‡ 106 35‡ 83 23§
 8.1 19.1 12‡ 18.2 11.6‡§ 6.5 7§
 5.0 5.1 4.3‡ 4.97 4.05‡§ 1.4 1.5§
.01 for within-group change from baseline to 2 years. Data for HOMA-IR are reported as median
roup comparisons and the Wilcoxon signed-rank sum test was used to examine within-group change.ubjeearRefe
eline
G
(n 
42
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February 8, 2011:732–9 Cardiovascular Remodeling With Weight Lossjority of subjects had concentric remodeling or concentric
LV hypertrophy. At the 2-year follow-up, the subjects in
the GBS group had decreases in interventricular septum
thickness, posterior wall thickness, relative wall thickness,
and LV mass/height2.7 (Table 2). The proportion of pa-
ients categorized as having LV hypertrophy decreased to a
reater extent in the GBS group than the nonsurgical
eference group. The LV diastolic and systolic volumes were
lightly higher in the GBS group at baseline but were not
ifferent than those in the reference group at the 2-year
ollow-up. The reduction in mass was related to reductions
n cavity volume and decreases in LV wall thickness.
elative wall thickness decreased in the GBS but not the
eference subjects. When missing values were filled in by
mputation or carry-forward methods, these main conclu-
ions were not changed (Table 2).
hanges in LA size after GBS. The net change in LA
olume at 2 years was a nonsignificant decrease in the
urgical group and an increase in the nonsurgical reference
roup (Table 2, Fig. 2). Although the absolute changes
ere modest, there was a relative increase of 4.1 ml in the
onsurgical group compared with the GBS group at 2 years
p  0.01). These changes are similar to those in a smaller
tudy examining LA volume after GBS (32).
hanges in RV size after GBS. At baseline, there were no
ifferences in RV size between GBS and nonsurgical sub-
Cardiac Geometry and Function at Baseline and 2-Year Follow-UpTable 2 Cardiac Geometry and Function at Baseline and 2-Yea
Variable
Baseline
Denied Surgery
Reference
(n  240)
Not Seeking Surgery
Reference
(n  271)
IVSd (cm) 1.14 0.24 1.18 0.21*
PWd (cm) 1.13 0.22 1.17 0.21*
LVIDd (cm) 4.47 0.65 4.43 0.62
RWT 0.53 0.16 0.54 0.16*
LVMI (g/m2.7) 44.0 13.0 46.5 12.0
LVMI (g/m2.7, imputed) 44.2 10.1 46.2 9.0*
LVMI (g/m2.7, carry forward) 43.9 12.6 46.5 11.8
LVMI A-L (g/m2.7) 39.4 11.0 40.1 11.5
Proportion with LV hypertrophy 67% 84%*
Endocardial FS (%) 35.4 6.6 36 6.5
LV EF (%) 64 90 65.7 8.6
Midwall FS (%) 16.0 3.6 15.3 2.9
Left atrial volume (ml) 53.9 19.1 54.1 16
LV diastolic volume (ml) 92 32 91.9 29.3*
LV systolic volume (ml) 34.6 15.0 31.8 14*
Cardiac output (l/min) 5.7 1.5 5.8 1.3
RV minor axis (cm) 3.1 0.7 3.2 0.65
RV length (cm) 7.5 0.8 7.53 0.82
RV diastolic area (cm2) 21.0 5.9 21.8 5.3
RV systolic area (cm2) 13.1 4.0 13.6 3.7
RV FAC (%) 37 13 38.6 8.5
% SpO2 90% 31 6 30 7
*p  0.05 versus GBS at baseline. †p  0.05 versus GBS at 2 years. ‡p  0.01 for within-group
EF  ejection fraction; FAC  fractional area change; FS  fractional shortening; IVSd  interv
2.7VMI  left ventricular mass index (g/m ); PWd  posterior wall thickness in diastole; RV  right vent
bbreviations as in Table 1.ects, except for RV minor axis dimension, which was
lightly smaller in GBS subjects (Table 2). At the 2-year
ollow-up, all measurements of RV size, with the exception
f RV annulus dimension, were smaller in GBS compared
ith nonsurgical subjects (Table 2). All measures of RV size
xcept RV annulus dimension correlated positively with
MI at visit 2. The strongest correlation (r  0.40; p 
.0001) was for RV systolic area. RV fractional area change
orrelated inversely with BMI (r  0.14; p  0.006).
hanges in LV and RV function after GBS. Left ven-
ricular endocardial fractional shortening and LV ejection
raction were not different between the GBS group and the
onsurgical group at baseline, and these measures did not
hange between the 2 visits in either group (Table 2).
owever, myocardial function as estimated by MWFS
ecreased slightly in the reference subjects (not significant)
nd increased in the GBS subjects at 2 years (Table 2, Fig. 2).
he difference between the groups was significant at 2 years.
idwall fractional shortening had a modest positive corre-
ation with exercise capacity (r  0.12; p  0.013). Calcu-
ated cardiac output decreased significantly at 2 years in the
BS group but did not change in the control group (Table 2).
ight ventricular systolic function, as assessed by fractional
rea change, was higher in the GBS group than the control
roup at the-2 year follow-up.
ow-Up
2 Years
GBS
(n  354)
Denied Surgery
Reference
(n  222)
Not Seeking Surgery
Reference
(n  254)
GBS
(n  338)
08 0.24 1.13 0.24† 1.16 0.24† 1.03 0.21‡
08 0.23 1.11 0.23† 1.14 0.23† 0.99 0.18‡
58 0.64 4.43 0.59 4.44 0.6 4.44 0.58‡
49 0.15 0.52 0.16† 0.53 0.15† 0.46 0.12‡
.0 12.0 44.0 12.0† 45.1 11.5.0† 38.0 10.0‡
.5 11.0 41.4 9.1† 43.7 10.0† 38.2 8.0‡
.0 12.3 42.5 11.4† 44.9 11.8† 38.4 10.0‡
.0 11.0‡ 39.0 7.0* 39.9 7.5† 35.0 7.0
64% 64% 72%† 56%‡
.9 8.1 35.5 6.8 35.4 6.5 35.5 6.3
63 11 65 8 64.4 8.3 65 8
.0 3.6 15.8 3.2† 15.4 3.1† 16.7 3.0‡
.3 17.0 56.7 14.5 58.5 16.6‡ 54.4 15.2
99 32 91 28 92.1 28.6 92 27
.9 18 32 12 32.5 13.2 33 13
.8 1.4 5.3 1.3† 5.3 1.29† 4.4 1.1‡
.0 0.6 3.3 0.6† 3.38 0.64† 3.1 0.6
.6 0.9 7.8 0.7†‡ 7.9 0.81†‡ 7.7 0.8
.7 5.4 23.6 5.0†‡ 23.9 5.7† 21.1 4.9
.0 3.4 14.6 3.5†‡ 14.9 4.1† 12.6 3.2
.0 9.2 37.6 9.5 37.6 8.4† 40.3 8.2‡
31 6.0 31 6† 30 6† 25 5
from baseline at 2 years.
lar septum thickness in diastole; LV  left ventricular; LVIDd  LV internal dimension in diastole;r Foll
1.
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Cardiovascular Remodeling With Weight Loss February 8, 2011:732–9Changes in LV filling pressures after GBS. The ratio of
E to E= is a noninvasive index of LV filling pressures (31).
t the beginning of the study (2001), tissue Doppler was
ot in widespread use. At 2 years after enrollment, E/E= was
lightly lower in the GBS than the control subjects (7.7 
.5 vs. 8.3  3.0). This suggested a modest improvement of
V relaxation rate, as shown in other studies (33,34), and/or
lowering of resting LV filling pressures after GBS-induced
eight loss. Even this small change may be clinically
eaningful because E/E= had a significant negative corre-
ation with exercise duration at the 2-year visit (r  0.16;
 0.002).
actors associated with changes in cardiac geometry and
unction. When changes from baseline were considered,
he factors that were independently associated with LV
ass index at visit 2 were change in BMI, age, and change
n diastolic blood pressure (Table 3). Surgical status, change
Figure 2
Changes in Cardiac Geometry and Function Between
Visit 1 (Baseline) and Visit 2 (2-Year Follow-Up) in
the GBS and Nonsurgical Control Groups
(A) Change in absolute left ventricular (LV) mass. (B) Change in left atrial (LA)
volume. (C) Change in midwall fractional shortening (MWFS); other abbrevia-
tions as in Figure 1.n waist circumference, and change in HOMA IR were notssociated with LV mass index. Surgical status and change
n BMI were not collinear based on formal testing. More-
ver, the main findings of the multivariable analysis were
nchanged if surgical status was left out of the initial model.
hen change in LV mass was used as the outcome variable
model 2, Online Appendix Table 2), change in BMI and
hange in LA volume were independently associated. Left
trial volume at 2 years was associated with sex, age, and
hange in diastolic blood pressure (Table 4). In model 2
Online Appendix Table 3), change in cardiac output and
hange in percent of sleep time with O2 saturation 90%
ere independently associated with change in LA volume.
he parameters that were independently associated with
WFS at 2 years were age and change in LV mass index
Table 5). In model 2 (Online Appendix Table 4), only
hange in BMI was independently associated with change in
WFS. Clinical factors associated with RV fractional area
hange at 2 years were age and severity of nocturnal
ypoxemia (Table 6).
iscussion
n this large prospective study, we found that marked
eight loss occurring via GBS was associated with stabili-
ation or partial reversal of the major geometric and
unctional cardiac changes associated with severe obesity.
ontinued obesity tended to be associated with modest
rogression of remodeling. The improvements in cardiac
eometry were present 2 years after surgery—a time point
hat is typically near the nadir of weight loss. This study
xpands on the findings of smaller studies, many of which
ad shorter durations of follow-up (35,36). Given the
owerful prognostic significance of increased LV mass and
A volume, our data suggest that favorable cardiac remod-
ling could represent one possible mechanism by which
BS improves survival in severe obesity (37).
eduction in LV mass after GBS. The reduction in LV
ass after GBS in our study (13.6%) is comparable to that
Factors Independently Associated With Left AtrialVolume at Visit 2 i Multivar ble AnalysisTable 4 Factors Independently Associa ed With Left AtrialVolume at Visit 2 in Multivariable Analysis
Variable
Standardized
Coefficient () t Statistic p Value
Sex 0.27 6.48 0.0001
Age 0.17 4.14 0.0001
Change in DBP 0.08 2.04 0.0423
Factors Independently Associated With LVMIat Visit 2 in Multivariable AnalysisTable 3 Fac ors Indepe dently Associated With LVMIat Visit 2 in Multivariable Analysis
Variable
Standardized
Coefficient () t Statistic p Value
Change in BMI 0.29 7.54 0.0001
Age 0.24 6.23 0.0001
Change in DBP 0.13 2.89 0.0040
LVMI  left ventricular mass/height2.7; other abbreviations as in Table 1.Abbreviations as in Table 1.
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imaging before and 1 year after GBS (14%) (38). The
decrease in LV mass after GBS appears to be larger than the
decrement in LV mass (approximately 8%) seen in pa-
tients who lost weight by diet (9.9 kg) (33). In this latter
study, as in most studies of diet-induced weight loss, weight
regain commenced at approximately 6 months after initia-
tion of the diet. Weight regain was associated with an
increase in LV mass. The durability of the favorable changes
in cardiac remodeling after GBS may be advantageous when
compared with changes occurring with lifestyle modification
alone.
Not surprisingly, multiple factors that could affect LV
mass change concomitantly in patients who lose large
amounts of weight. Interestingly, change in BMI was the
anthropometric variable most significantly correlated with
LV mass (Table 3, Online Appendix Table 2). Whereas
other studies have emphasized visceral adiposity as a risk
factor for LV remodeling (39,40), our data did not show an
independent relationship between LV mass index and waist
circumference when BMI was included in the multivariable
model. These findings suggest that generalized obesity may
be a more important driver of cardiac hypertrophy than
central obesity. All subjects in this severely obese group had
increased waist circumference, potentially explaining a lack
of relationship between waist circumference and LV mass.
In contrast to cardiac hypertrophy, visceral adiposity, rather
than overall body size, seems to more strongly influence the
development of metabolic syndrome and atherosclerosis
(41). One mechanism that may link larger body size to
increased LV mass is the need for higher cardiac output.
Although we found that cardiac output decreased after GBS
(Table 2), cardiac output did not have an independent
relationship with LV mass in multivariable analysis. This
suggests the effect of cardiac output is mediated, at least in
part, through interaction with other factors. Change in
cardiac output was an independent predictor of change
in LA volume (Online Appendix Table 3). It seems intui-
tive that the reduction in LV mass in the GBS group could
be related to the lowering of blood pressure. However,
change in blood pressure was significantly associated with
absolute LV mass (model 1) but not change in LV mass
(model 2). Moreover, even when controlling for blood
pressure, change in BMI retained an independent associa-
tion with LV mass index in both models. Surgical status
Factors Independently Associated With LVMidwall FS at Visit 2 in Mult variable AnalysisTable 5 Factors Independently Associated With LVMidwall FS at Visit 2 in Multivariable Analysis
Variable
Standardized
Coefficient () t Statistic p Value
Age 0.237 3.18 0.0018
Change in LVMI 0.176 2.35 0.0197
Change in E/E= 0.109 1.47 0.1439
E early diastolic mitral flow velocity; E= early diastolic myocardial velocity; other abbreviations
s in Table 2.(yes/no) was not independently associated with improvedLV mass. Thus, our data suggest that the improvements in
cardiac geometry following GBS are more likely due to
weight loss and not some other aspect of bypassing the distal
stomach and duodenum (e.g., changes in hormones secreted
from the gastrointestinal tract). The direct effects of de-
creasing body size, in conjunction with several other bene-
ficial hemodynamic changes occurring in the setting of
weight loss, can favorably impact LV remodeling. Similar
factors are likely associated with favorable changes in RV
size and function.
Left atrial volume decreased slightly but not significantly
in patients undergoing GBS as compared with the nonsur-
gical patients in whom LA volume increased over time. Left
atrial volume at visit 2 was related to age, sex, and changes
in blood pressure, but not waist circumference or surgical
status. In addition, change in LA volume was related to
change in cardiac output and severity of nocturnal hypox-
emia. Clearly there are complex interrelationships between
cardiac geometry and the many physiologic and hemody-
namic factors that change after GBS.
Systolic function after GBS. Even though LV endocardial
fractional shortening and LV ejection fraction were normal
at rest in our subjects, MWFS, a better index of myocardial
function in hypertrophied hearts (16), was reduced. Other
investigators have found similar mild changes in myocardial
function in obese subjects using tissue Doppler or strain
imaging (8,9). Although it is unknown if these subtle
abnormalities of systolic dysfunction progress over time or
lead to clinical heart failure in the absence of coronary artery
disease, it is still encouraging to see evidence of improve-
ment after weight loss. Although the magnitude of the
changes we observed in systolic function were small,
MWFS showed a significant positive correlation with exer-
cise capacity, suggesting that this change could have phys-
iologic relevance.
Age and effects of GBS. More advanced age was signifi-
cantly associated with worse cardiac remodeling and worse
LV and RV function in all of the multivariable analyses.
This finding suggests that older age, and presumably longer
durations of obesity, could limit some of the beneficial
cardiac effects of GBS. Surgical treatment might be more
beneficial when offered to younger patients. More investi-
gation will be needed to specifically address this important
question.
Study limitations. The GBS and reference groups had
baseline differences in several clinical characteristics. Those
in the GBS group were younger but had higher BMI and
Factors Independently Associated With RVractional Area Change at Visi 2 in MultivariableAnalysis
Table 6
Factors Independently Associated With RV
Fractional Area Change at Visit 2 in Multivariable
Analysis
Variable
Standardized
Coefficient () t Statistic p Value
% of sleep with SpO2 90% 0.184 2.83 0.0050
Age 0.121 2.18 0.0298Abbreviations as in Table 2.
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surgery group and the GBS group (which were more similar
at baseline) showed similar results to analyses comparing the
surgical patients with the combined reference group (Tables
1 and 2). Thus, we do not think these baseline differences
ffected our main conclusions about the effects of weight
oss. In addition, to further minimize baseline differences,
e used 1 set of multivariable models that only looked at
hanges from baseline. Because our study was not random-
zed, it is possible that selection bias influenced the results.
e cannot state with certainty whether the favorable effects
e observed resulted purely from weight loss or from some
ther aspect of GBS. This is potentially important because
ypassing the distal stomach and proximal small bowel may
nduce hormonal or other effects that are different from
hose purely owing to weight loss. Our data suggest that
eight loss is more important than bariatric surgery, per se.
o sort this out, it would be ideal to compare the changes
chieved after GBS with those in a group who lost compa-
able amounts of weight via lifestyle modification (e.g., diet
nd exercise). Unfortunately, this is nearly impossible to do
iven the widely acknowledged failure of lifestyle modifica-
ion to produce sustained weight loss in the severely obese
opulation. Changes in plasma volume might also contrib-
te to the LV remodeling. We did not measure plasma
olume in our subjects. Cardiac output, which is related to
lasma volume, was reduced after GBS. Cardiac output was
ot independently associated with LV mass but was related
o LA volume in multivariable analysis. A factor that might
imit the ability to generalize our conclusions is the fact that
he majority of our subjects had well-controlled blood
ressure and normal fasting glucose and glycosylated hemo-
lobin levels at baseline (Table 1). Although our patients
ay have been “healthier” than comparably obese subjects in
ther geographic areas or of different ethnic backgrounds,
he relative good health of our subjects would likely mini-
ize the favorable effects of GBS compared with what
ight be seen in obese populations with more severe
omorbidities. Thus, the beneficial changes after GBS
ight be even more pronounced in other populations. On
he other hand, it is possible that the combination of severe
besity and poorly controlled hypertension or diabetes could
ead to irreversible cardiac remodeling and dysfunction that
ould not improve after GBS. Such effects might explain
he high mortality seen after GBS in older men that was
eported in one study (42). Additional studies in different
atient populations will be required to address these issues.
erspectives. Our results in a large cohort of severely obese
ubjects showed that GBS was associated with sustained
reverse” cardiac remodeling and modest improvements in
yocardial function. These data help to fill some of the
reviously identified gaps in bariatric surgical published
eports (42). Given the powerful prognostic significance of
ncreased LV mass and LA volume, our findings suggest
ossible mechanisms by which GBS could lead to enhanced
urvival in severe obesity (37). Despite these favorableesults, continued caution is still warranted because there are
otential untoward effects of GBS that may take many years
o become manifest (i.e., osteoporosis or micronutrient
eficiencies). However, given that cardiovascular disease is
he leading cause of excess mortality in the obese population
43), the potential risks are unlikely to outweigh the
emonstrable benefits of surgical intervention. In addition
o the structural and functional changes in the heart that we
eport herein, other investigators have estimated that GBS
hould result in substantial reductions in the risk of devel-
ping atherosclerotic coronary vascular disease as a result of
mprovements in blood pressure, lipid levels, and insulin
esistance/diabetes (44).
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